Humana partners with Philips to monitor MA members

Humana, one of the nation’s largest health insurance providers, has partnered with health technology company Philips to offer remote monitoring for Humana’s high-risk Medicare Advantage members to cut down on readmissions and improve care delivery in real time.

The partnership includes two programs that leverage Philips’ medical alert service s and remote member monitoring (RMM) to monitor at-risk MA members. The partnership aims to provide more timely interventions and improve care delivery through population management. The monitoring will help close the gap of the 57% of MA patients who are released from a hospital stay without any direct monitoring by a healthcare professional.

Humana is also one of the largest providers of MA plans, with 3.56 million total members in 2018. Philips’ remote member monitoring solutions are part of its overall population health management portfolio, which includes services, analytics and devices.

“Our goal is to continue to find ways to help our Medicare Advantage members stay longer and safer in their homes,” Susan Diamond, Humana’s home business segment president, said in a statement. “We believe our work with Philips will help offer our members and their caregivers more in-home support and help them to stay engaged and focused on prevention.”

Humana will identify at-risk MA members and offer them the remote monitoring services, through the Philips Lifeline medical alert service, AutoAlert. Philips CareSage will support all detection technology through predictive analytics. Seniors in the program will have around-the-clock access to trained care specialists who can dispatch help when needed.

Humana is also leveraging Philips remote monitoring and its associated connected measurement devices to increase the touchpoints with congestive heart failure (CHF) patients, who represent one of the costliest groups without timely and effective interventions.

The insurer is creating a pilot for a select group of MA members with severe CHF, outfitting them with interactive tablets to sync data from connected measurement devices wirelessly. The devices include a weight scale, blood pressure monitor and pulse oximeter to allow members to monitor their own health information and share it with their care manager.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.